Published in Int J Clin Exp Pathol on May 15, 2014
Solitary cardiac metastasis of uterine cervical cancer with antemortem diagnosis: A case report and literature review. Oncol Lett (2016) 0.88
ClC-3 chloride channel modulates the proliferation and migration of osteosarcoma cells via AKT/GSK3β signaling pathway. Int J Clin Exp Pathol (2015) 0.77
Over-expression of lysine-specific demethylase 1 predicts tumor progression and poor prognosis in human esophageal cancer. Int J Clin Exp Pathol (2014) 0.77
T cell factor-4 functions as a co-activator to promote NF-κB-dependent MMP-15 expression in lung carcinoma cells. Sci Rep (2016) 0.75
Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis. Int J Clin Exp Pathol (2015) 0.75
Heterophyllin B inhibits the adhesion and invasion of ECA‑109 human esophageal carcinoma cells by targeting PI3K/AKT/β‑catenin signaling. Mol Med Rep (2015) 0.75
Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci U S A (2016) 0.75
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol (2002) 5.73
B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res (2004) 4.65
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol (2009) 3.55
Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol (2000) 3.53
MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J (2002) 1.77
Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci (2002) 1.69
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res (2010) 1.60
Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res (1997) 1.60
B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother (2011) 1.34
Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer (2009) 1.23
Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem (2004) 1.18
Immunochemical staining of MT2-MMP correlates positively to angiogenesis of human esophageal cancer. Anticancer Res (2010) 1.12
High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer (1996) 1.11
Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. Exp Cell Res (2006) 1.11
Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival. Anticancer Res (2010) 1.03
Identification of MMP-15 as an anti-apoptotic factor in cancer cells. J Biol Chem (2005) 1.01
Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol (2000) 1.01
Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev Biol (2011) 0.99
Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. J Surg Res (2007) 0.98
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. Am J Clin Pathol (2001) 0.97
Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP. J Clin Endocrinol Metab (2004) 0.96
Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient. Acta Histochem (2009) 0.90
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol (2002) 0.89
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages. Int J Oncol (2012) 0.85
MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. PLoS One (2012) 0.79
Immunolocalization of membrane-type 1 MMP in human rheumatoid synovium tissues. Int J Clin Exp Pathol (2015) 0.75